Skip to Main content Skip to Navigation
Journal articles

Optical properties of photodynamic therapy drugs in different environments: the paradigmatic case of temoporfin

Abstract : Computational tools have been used to study the photophysical and photochemical features of photosensitizers in photodynamic therapy (PDT) – a minimally invasive, less aggressive alternative for cancer treatment. PDT is mainly based on the activation of molecular oxygen through the action of a photoexcited sensitizer (photosensitizer). Temoporfin, widely known as mTHPC, is a second-generation photosensitizer, which produces the cytotoxic singlet oxygen when irradiated with visible light and hence destroys tumor cells. However, the bioavailability of the mostly hydrophobic photosensitizer, and hence its incorporation into cells, is fundamental to achieve the desired effect on malignant tissues via PDT. In this study, we focus on the optical properties of the temoporfin chromophore in different environments – in vacuo, in solution, encapsulated in drug delivery agents, namely cyclodextrin, and interacting with a lipid bilayer.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-lorraine.fr/hal-02912976
Contributor : Antonio Monari <>
Submitted on : Friday, August 7, 2020 - 10:52:26 AM
Last modification on : Friday, November 13, 2020 - 8:20:06 AM

Links full text

Identifiers

Collections

Citation

Busenur Aslanoglu, Ilya Yakavets, Vladimir Zorin, Henri-Pierre Lassalle, Francesca Ingrosso, et al.. Optical properties of photodynamic therapy drugs in different environments: the paradigmatic case of temoporfin. Physical Chemistry Chemical Physics, Royal Society of Chemistry, 2020, 22 (29), pp.16956-16964. ⟨10.1039/D0CP02055a⟩. ⟨hal-02912976⟩

Share

Metrics

Record views

64